Terms: = Breast cancer AND TCF7L2, ENSG00000148737, 6934, TCF-4 AND Prognosis
8 results:
1. Construction of a prognostic model for triple-negative breast cancer based on immune-related genes, and associations between the tumor immune microenvironment and immunological therapy.
Zhu Y; Tao LF; Liu JY; Wang YX; Huang H; Jiang YN; Qian WF
Cancer Med; 2023 Jul; 12(14):15704-15719. PubMed ID: 37306188
[TBL] [Abstract] [Full Text] [Related]
2. Development of a Novel Immune-Related Gene Prognostic Index for breast cancer.
Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
Front Immunol; 2022; 13():845093. PubMed ID: 35558081
[TBL] [Abstract] [Full Text] [Related]
3. Circ-PRMT5 promotes breast cancer by the miR-509-3p/tcf7l2 axis activating the PI3K/AKT pathway.
Wu D; Jia H; Zhang Z; Li S
J Gene Med; 2021 Feb; 23(2):e3300. PubMed ID: 33277756
[TBL] [Abstract] [Full Text] [Related]
4. The Wnt3a/β-catenin/tcf7l2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA LUCAT1/miR-5582-3p/tcf7l2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract] [Full Text] [Related]
6. Molecular mechanisms of breast cancer metastasis by gene expression profile analysis.
Zheng T; Wang A; Hu D; Wang Y
Mol Med Rep; 2017 Oct; 16(4):4671-4677. PubMed ID: 28791367
[TBL] [Abstract] [Full Text] [Related]
7. Wnt-β-catenin-tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer.
Ravindranath A; Yuen HF; Chan KK; Grills C; Fennell DA; Lappin TR; El-Tanani M
Br J Cancer; 2011 Aug; 105(4):542-51. PubMed ID: 21772333
[TBL] [Abstract] [Full Text] [Related]
8. Effects of EpCAM overexpression on human breast cancer cell lines.
Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
[TBL] [Abstract] [Full Text] [Related]
